SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021976
Filing Date
2023-05-15
Accepted
2023-05-15 08:05:19
Documents
76
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20230331.htm   iXBRL 10-Q 3188701
2 EX-10.1 stro-ex10_1.htm EX-10.1 82698
3 EX-10.2 stro-ex10_2.htm EX-10.2 254581
4 EX-10.3 stro-ex10_3.htm EX-10.3 97093
5 EX-31.1 stro-ex31_1.htm EX-31.1 19216
6 EX-31.2 stro-ex31_2.htm EX-31.2 19391
7 EX-32.1 stro-ex32_1.htm EX-32.1 9662
8 EX-32.2 stro-ex32_2.htm EX-32.2 9692
  Complete submission text file 0000950170-23-021976.txt   11853295

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stro-20230331_def.xml EX-101.DEF 302140
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20230331.xsd EX-101.SCH 73113
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stro-20230331_cal.xml EX-101.CAL 47485
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20230331_lab.xml EX-101.LAB 547107
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20230331_pre.xml EX-101.PRE 430904
70 EXTRACTED XBRL INSTANCE DOCUMENT stro-20230331_htm.xml XML 2280130
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 23918530
SIC: 2836 Biological Products, (No Diagnostic Substances)